secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0001062822-23-000028
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon amends Oxford loan, draws $50M; $25M tranche available Dec 2023 with better terms
--------------------------------------------------------------------------------

- Amended Oxford loan: $75M draw split; $50M drawn June 28, $25M available Dec 2023.
- Interest rate index switches from 30-day LIBOR to 1-month CME Term SOFR; spread cut from 7.90% to 7.00% for third/fourth tranches.
- On $50M draw, Lexicon issued Oxford a warrant for 183,824 shares at $2.38/share (5-year term).
- Fourth tranche ($25M) available for draw Dec 1-31, 2023; requires FDA approval of sotagliflozin (already acknowledged).
- Minimum cash covenant and unused fee only apply if fourth tranche is drawn or not fully drawn, respectively.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000106282223000028/0001062822-23-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000106282223000028/lxrx-20230623.htm
  HTML page:      https://secwatch.observer/filing/0001062822-23-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer